T. Rowe Price Associates’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55K | Buy |
16,314
+3,245
| +25% | +$10.9K | ﹤0.01% | 2993 |
|
|
2025
Q1 | $51K | Buy |
13,069
+618
| +5% | +$2.41K | ﹤0.01% | 2925 |
|
|
2024
Q4 | $77K | Buy |
12,451
+2,167
| +21% | +$13.4K | ﹤0.01% | 2872 |
|
|
2024
Q3 | $56K | Hold |
10,284
| – | – | ﹤0.01% | 2913 |
|
|
2024
Q2 | $35K | Sell |
10,284
-863
| -8% | -$2.94K | ﹤0.01% | 2886 |
|
|
2024
Q1 | $45K | Buy |
+11,147
| New | +$45K | ﹤0.01% | 2883 |
|
|
2022
Q4 | – | Sell |
-280,120
| Closed | -$4.68M | – | 2945 |
|
|
2022
Q3 | $4.68M | Sell |
280,120
-72,989
| -21% | -$1.22M | ﹤0.01% | 1220 |
|
|
2022
Q2 | $4.94M | Sell |
353,109
-220,903
| -38% | -$3.09M | ﹤0.01% | 1421 |
|
|
2022
Q1 | $9.27M | Sell |
574,012
-213,653
| -27% | -$3.45M | ﹤0.01% | 1374 |
|
|
2021
Q4 | $16.9M | Sell |
787,665
-661,303
| -46% | -$14.2M | ﹤0.01% | 1324 |
|
|
2021
Q3 | $21.3M | Hold |
1,448,968
| – | – | ﹤0.01% | 1278 |
|
|
2021
Q2 | $28.2M | Buy |
1,448,968
+13,714
| +1% | +$267K | ﹤0.01% | 1216 |
|
|
2021
Q1 | $41.9M | Buy |
+1,435,254
| New | +$41.9M | ﹤0.01% | 1062 |
|